Project Details
Description
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 12/19/17 → 1/4/22 |
Funding
- UNIVERSITY OF MICHIGAN
- PROMETHEUS LABORATORIES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.